NEW YORK (GenomeWeb) – Hologic said after the close of the market on Wednesday that its revenues for the fiscal third quarter inched up 1 percent year over year.

For the three months ended June 28, the company recorded $632.6 million in revenues, compared to $626.1 million in the year-ago quarter, and comfortably above the average analyst estimate of $621.9 million.

Product revenues came in at $529.3 million, down slightly from $529.9 million in Q3 2013, while service and other revenues rose to $103.3 million from $96.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.